About Xenome
Core values
Leadership
Board of Directors
Management
Pipeline
Xen2174
Discovery Platform
FAQ
Announcements
Company Presentation
Scientific Publications & Posters
Latest Announcements
Julie Cherrington Appointed Chair of Xenome's Board of Directors - Experienced Industry Executive to Lead in Critical Phase
Xenome completes A$8.0 million Financing - Funds to Advance Proof of Concept Clinical Studies
Xenome names Michael Aldridge as Executive Director - 25 May 2010
©2012 Xenome Ltd ABN 60 081 612 384
Disclaimer
Print
Brisbane | Melbourne | San Diego
